Opioids in patients with COPD and refractory dyspnea: literature review and design of a multicenter double blind study of low dosed morphine and fentanyl (MoreFoRCOPD)

BACKGROUND: Refractory dyspnea or breathlessness is a common symptom in patients with advanced chronic obstructive pulmonary disease (COPD), with a high negative impact on quality of life (QoL). Low dosed opioids have been investigated for refractory dyspnea in COPD and other life-limiting condition...

Descripción completa

Detalles Bibliográficos
Autores principales: van Dijk, Marlies, Mooren, Kris J. M., van den Berg, Jan-Willem K., van Beurden-Moeskops, Wendy J. C., Heller-Baan, Roxane, de Hosson, Sander M., Lam-Wong, Wai Yee, Peters, Liesbeth, Pool, Karin, Kerstjens, Huib A. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431258/
https://www.ncbi.nlm.nih.gov/pubmed/34507574
http://dx.doi.org/10.1186/s12890-021-01647-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431258/
https://www.ncbi.nlm.nih.gov/pubmed/34507574
http://dx.doi.org/10.1186/s12890-021-01647-8

Ejemplares similares